Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1

BackgroundElevated systolic blood pressure (SBP) and resting heart rate (RHR) contribute to pathogenesis of diabetic complications. They increase inflammation which can upregulate leucine-rich α-2-glycoprotein 1 (LRG1), an emerging biomarker of cognitive decline.ObjectiveTo examine association between double product (DP, derived from multiplying SBP and RHR) and cognitive function in type 2 diabetes (T2D), with possible mediation by plasma LRG1.MethodsIn this prospective cohort of 1319 patients (mean age 62.5 ± 7.3), plasma LRG1 was measured with enzyme-linked immunosorbent assay. Cognitive function was assessed using Repeatable Battery for Assessment of Neuropsychological Status (RBANS). Cross-lagged panel analysis was done to examine temporal relationship between DP and cognitive function.ResultsBaseline DP was associated with lower baseline RBANS total score (adjusted coefficient = -2.43; 95%CI -4.76, -0.10; p = 0.041). 586 patients were followed up to 8.6 years. Baseline DP was associated with follow-up RBANS total score (adjusted coefficient = -3.80; 95%CI -6.51, -1.10; p = 0.006). It was also associated with lower follow-up RBANS scores in immediate memory and delayed memory with adjusted coefficients -4.38 (95%CI -8.49, -0.28; p = 0.036) and -5.12 (95%CI -9.88, -0.35; p = 0.035) respectively. In cross-lagged panel analysis, standardized effect size of baseline DP on follow-up RBANS total score (β = -0.08; p = 0.002) was larger than that of baseline RBANS total score on follow-up DP (β = -0.04; p = 0.266). LRG1 accounted for 14.7% of the association in mediation analysis (p = 0.035).ConclusionsDP was independently associated with cognitive function with possible mediation by LRG1. DP preceded decline in cognitive function. DP may be potential intervention and monitoring target for prevention of cognitive impairment and possibly Alzheimer's disease in T2D.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2025-05-22
DOI
https://doi.org/10.1177/13872877251344881
Citations
1
Primary Topic
Clusterin in disease pathology
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1

Huili Zheng, Keven Ang, Tavintharan Subramaniam, Bhuvaneswari Pandian et al.
1 citations
Journal of Alzheimer s Disease
Clusterin in disease pathology
1.05
article

Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1

Huili Zheng, Keven Ang, Tavintharan Subramaniam, Bhuvaneswari Pandian, Tak Kwan, Serena Low, Chee Fang Sum, Sharon Li Ting Pek, Jianjun Liu, Wern Ee Tang, Su Chi Lim, Ziliang Lim, Angela Moh
article en
1 citations

Abstract

BackgroundElevated systolic blood pressure (SBP) and resting heart rate (RHR) contribute to pathogenesis of diabetic complications. They increase inflammation which can upregulate leucine-rich α-2-glycoprotein 1 (LRG1), an emerging biomarker of cognitive decline.ObjectiveTo examine association between double product (DP, derived from multiplying SBP and RHR) and cognitive function in type 2 diabetes (T2D), with possible mediation by plasma LRG1.MethodsIn this prospective cohort of 1319 patients (mean age 62.5 ± 7.3), plasma LRG1 was measured with enzyme-linked immunosorbent assay. Cognitive function was assessed using Repeatable Battery for Assessment of Neuropsychological Status (RBANS). Cross-lagged panel analysis was done to examine temporal relationship between DP and cognitive function.ResultsBaseline DP was associated with lower baseline RBANS total score (adjusted coefficient = -2.43; 95%CI -4.76, -0.10; p = 0.041). 586 patients were followed up to 8.6 years. Baseline DP was associated with follow-up RBANS total score (adjusted coefficient = -3.80; 95%CI -6.51, -1.10; p = 0.006). It was also associated with lower follow-up RBANS scores in immediate memory and delayed memory with adjusted coefficients -4.38 (95%CI -8.49, -0.28; p = 0.036) and -5.12 (95%CI -9.88, -0.35; p = 0.035) respectively. In cross-lagged panel analysis, standardized effect size of baseline DP on follow-up RBANS total score (β = -0.08; p = 0.002) was larger than that of baseline RBANS total score on follow-up DP (β = -0.04; p = 0.266). LRG1 accounted for 14.7% of the association in mediation analysis (p = 0.035).ConclusionsDP was independently associated with cognitive function with possible mediation by LRG1. DP preceded decline in cognitive function. DP may be potential intervention and monitoring target for prevention of cognitive impairment and possibly Alzheimer's disease in T2D.

Journal of Alzheimer s DiseaseVol. 106(2)
National University of Singapore (SG), Nanyang Technological University (SG), Khoo Teck Puat Hospital (SG), SingHealth Polyclinics (SG), National University Health System (SG)
National Medical Research Council
Good health and well-being
Openalex Percentile: Top 22%
Clusterin in disease pathology
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.